Homocysteine induces protein kinase C activation and stimulates c-Fos and lipoprotein lipase expression in macrophages

Diabetes

Volumn 51, Issue 4, 2002, Pages 1180-1187

  Beauehamp, Marie Claude ^a   Renier, Geneviève ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE; LIPOPROTEIN LIPASE; MESSENGER RNA; PROTEIN C FOS; PROTEIN KINASE C;

AMINO ACID METABOLISM; ANIMAL CELL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0036224169     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.4.1180     Document Type: Article

References (65)

1. Hyperhomocysteinemia: An independent risk factor for vascular disease
2. Hyperhomocysteinemia and low pyridoxal phosphate: Common and independent reversible risk factors for coronary artery disease
3. Plasma homocyst(e)ine levels and graded risk for myocardial infarction: Findings in two populations at contrasting risk for coronary heart disease
4. Low whole-blood S-adenosylmethionine and correlation between 5-methyltetrahydrofolate and homocysteine in coronary artery disease
5. Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial
6. Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in Japanese patients with type 2 diabetes
7. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus. A population-based study
8. Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease
9. Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria
10. Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-Year follow-up of the Hoorn Study
11. Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis
12. Homocysteine signal cascade: Production of phospholipids, activation of protein kinase C, and the induction of c-fos and c-myb in smooth muscle cells
13. Acute methionine load-induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophage-derived tissue factor activity in rats
14. Lipoprotein lipase secretion by human monocyte-derived macrophages
15. Modification of low density lipoprotein by lipoprotein lipase or hepatic lipase enhances uptake and cholesterol accumulation in cells
16. Lipoprotein lipase-mediated uptake and degradation of low density lipoproteins by fibroblasts and macrophages
17. Can lipoprotein lipase be the culprit in cholesteryl ester accretion in smooth muscle cells in atheroma?
18. Lipoprotein lipase (LPL) affects low density lipoprotein (LDL) flux through vascular tissue: Evidence that LPL increases LDL accumulation in vascular tissue
19. Apoliproprotein E modulates low density lipoprotein retention by lipoprotein lipase anchored to the subendothelial matrix
20. Induction of tumor necrosis factor alpha gene expression by lipoprotein lipase
21. Differentiation of human monocytes to monocyte-derived macrophages is associated with increased lipoprotein lipase-induced tumor necrosis factor-alpha expression and production. A process involving cell surface proteoglycans and protein kinase C
22. Lipoprotein lipane enhances human monocyte adhesion to aortic endothelial cells
23. Lipoprotein lipase-mediated lipolysis of very low density lipoproteins increases monocyte adhesion to aortic endothelial cells
24. Lipoprotein lipase can function as a monocyte adhesion protein
25. Proliferative effect of lipoprotein lipase on human vascular smooth muscle cells
26. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo
27. Macrophage lipoprotien lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice
28. Effects of heterozygous lipoprotein lipase deficiency on diet-induced atherosclerosis in mice
29. Role of macrophage-derived lipoprotein lipase in Lipoprotem metabolism and atherosclerosis
30. Upregulation of macrophage lipoprotein lipase in patients with type 2 diabetes: Role of peripheral factors
31. Stimulatory effect of glucose on macrophage lipoprotien lipase expression and production
32. Direct regulatory effect of fatty acids on macrophage lipoprotein lipase: Potential role of PPARs
33. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose
34. Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis
35. The structure of the mouse lipoprotein lipase gene: A B1 repetitive element is inserted into the 3′-untranslated region of the mRNA
36. Cloning and characterization of the promoter of the murine lipoprotein lipase-encoding gene: Structural and functional analysis
37. A sandwich-enzyme immunoassay for the quantification of lipoprotein lipase and hepatic triglyceride lipase in human postheparin plasma using monoclonal antibodies to the corresponding enzymes
38. New fluorogenic triacylglycerol analogs as substrates for the determination and chiral discrimation of lipase activities
39. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
40. Lipoprotein lipase gene expression: Physiological regulators at the transcriptional and post-transcriptional level
41. Cloning, sequencing and structural analysis of 976 base pairs of the promoter sequence for the rat lipoprotein lipase gene. Comparison with the mouse and human sequences
42. 2-terminal kinase and promoter response element
43. ERK2 activation by homocysteine in vascular smooth muscle cells
44. Homocysteine stimulates MAP kinase in bovine aortic smooth muscle cells
45. Homocysteine and alpha-lipoic acid regulate p44/42 MAP kinase phosphorylation in NIH/3T3 cells
46. The critical role of Shc in insulin-like growth factor-I-mediated mitogenesis and differentiation in 3T3-L1 preadipocytes
47. Biphasic and synergistic activation of p44mapk (ERK1) by growth factors: Correlation between late phase activation and mitogenicity
48. Differential regulation of macrophage peroxisome proliferator-activated receptor expression by glucose. Role of peroxisome proliferator-activated receptors in lipoprotein lipase gene expression
49. PPARα and PPARγ activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene
50. Plasma homocysteine concentration related to diet, endothelial function and mononuclear cell gene expression among male hyperlipidaemic smokers
51. Advanced glycation end product-induced peroxisome proliferator-activated receptor gamma gene expression in the cultured mesangial cells
52. Induction of CD36 expression by oxidized LDL and 11-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma
53. Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor alpha by phosphorylation of a ligand-independent trans-activating domain
54. Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase
55. Interdomain communication regulating ligand binding by PPAR-gamma
56. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ
57. Phosphorylation of peroxisome proliferator-activated receptor alpha in rat Fao cells and stimulation by ciprofibrate
58. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: A new link between diabetic nephropathy and cardiovascular disease?
59. Hyperhomocysteinemia in poorly controlled type 2 diabetes patients
60. The role of lipoprotein lipase in the metabolism of triglyceride-rich lipoproteins by macrophages
61. Apolipoprotein-E and lipoprotein lipase secreted from human monocyte-derived macrophages modulate very low density lipoprotein uptake
62. Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrix
63. Lipoprotein lipase and sphingomyelinase synergistically enhance the association of atherogenic lipoproteins with smooth muscle cells and extracellular matrix. A possible mechanism for low density lipoprotein and lipoprotein(a) retention and macrophage foam cell formation
64. Lipoprotein lipase increases low density lipoprotein retention by subendothelial cell matrix
65. The response-to-retention hypothesis of early atherogenesis